{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:47:35Z","timestamp":1783522055737,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.phymed.2010.07.002","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T04:22:04Z","timestamp":1282537324000},"page":"219-223","source":"Crossref","is-referenced-by-count":24,"title":["Isolation of anxiolytic principle from ethanolic root extract of Cardiospermum halicacabum"],"prefix":"10.1016","volume":"18","author":[{"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Murugananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2010.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/appi.ps.51.9.1130","article-title":"A review of herbal medicines for psychiatric disorder","volume":"51","author":"Beaubrum","year":"2000","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.phymed.2010.07.002_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(87)90006-2","article-title":"Anxiogenic effects of methyl-h carboline-carboxylate in a light\/dark choice situation","volume":"28","author":"Belzung","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0091-3057(89)90033-6","article-title":"Exploration of mice in a black and white test box: validation as a model of anxiety","volume":"32","author":"Costall","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-3057(01)00485-3","article-title":"The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism","volume":"68","author":"Eguchi","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.v60n0702","article-title":"The economic burden of anxiety disorders in the 1990s","volume":"60","author":"Greenberg","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0091-3057(95)02122-1","article-title":"Central nervous system characterization of new cholecystokinin B antagonist LY288513","volume":"53","author":"Helton","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0040","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/S0040-4039(01)86597-7","article-title":"Cardiosperminsulfate\u2014a sulphur containing cyanogenic glucoside from Cardiospermum grandiflorum","volume":"20","author":"Hubel","year":"1979","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.phymed.2010.07.002_bib0045","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/13543776.6.10.1047","article-title":"Novel anxiolytic agents-1994-to present","volume":"6","author":"Jordan","year":"1996","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phymed.2010.07.002_bib0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.1991.tb01831.x","article-title":"Benzodiazepine problems","volume":"86","author":"Lader","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.phymed.2010.07.002_bib0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0091-3057(00)00419-6","article-title":"Differences in anxiety-related behavior and response to diazepam in BALB\/cByJ and C57BL\/6J strains of mice","volume":"67","author":"Lepicard","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phymed.2010.07.002_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00634451","article-title":"An evaluation of the elevated plus-maze using the novel anxiolytic buspirone","volume":"99","author":"Moser","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phymed.2010.07.002_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1746-4269-2-43","article-title":"Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India","volume":"2","author":"Muthu","year":"2006","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"10.1016\/j.phymed.2010.07.002_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.phymed.2010.07.002_bib0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effect on exploratory activity in elevated plus maze: a novel test of anxiety in rats","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0278-5846(01)00330-X","article-title":"Anxiolytic-like effects of Kava-Kava in the elevated plus maze test\u2014a comparison with diazepam","volume":"26","author":"Rex","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/S0007125000293458","article-title":"Health economics and cost implications of anxiety and other mental disorders in the United States","volume":"173","author":"Rice","year":"1998","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0095","first-page":"4","article-title":"The clinical presentation of generalized anxiety in primarycare setting: practical concepts of classification and management","volume":"58","author":"Rickels","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phymed.2010.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.pnpbp.2007.05.009","article-title":"Anxiolytic-like effects of obovatol isolated from Magnolia obovata: Involvement of GABA\/benzodiazepine receptors complex","volume":"31","author":"Seo","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0110","first-page":"95","article-title":"Cardiospermum halicacabum suppress the production of TNF-alpha nitric oxide by human peripheral blood mononuclear cells","volume":"9","author":"Venkteshbabu","year":"2006","journal-title":"Afr. J. Biomed. Res."},{"key":"10.1016\/j.phymed.2010.07.002_bib0115","first-page":"15","article-title":"Generalized anxiety disorder: nature and course","volume":"62","author":"Wittchen","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2010.07.002_bib0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0091-3057(91)90078-G","article-title":"A fully automated light\/dark apparatus useful for comparing anxiolytic agents","volume":"40","author":"Young","year":"1991","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711310002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711310002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:07:53Z","timestamp":1559441273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711310002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":24,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0944711310002242"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2010.07.002","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}